Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 18 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

31%

5 of 16 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

Phase 1
6(46.2%)
Phase 2
5(38.5%)
N/A
1(7.7%)
Phase 3
1(7.7%)
13Total
Phase 1(6)
Phase 2(5)
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT04881942Not ApplicableCompleted

Characterization of Selected Aerosol Constituents Levels in the Exhaled Breath of Adult e-Vapor Users

Role: collaborator

NCT03186378Phase 2Completed

Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.

Role: collaborator

NCT01597401Phase 1Completed

A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease

Role: collaborator

NCT02506179Completed

Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis

Role: collaborator

NCT01387802Completed

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Role: collaborator

NCT01559038Completed

Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis

Role: collaborator

NCT02232893Phase 2Completed

Effect of TU-100 in Patients Undergoing Laparoscopic Colectomy

Role: collaborator

NCT01387815Completed

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis

Role: collaborator

NCT02581189Completed

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada

Role: collaborator

NCT02602184Phase 2Unknown

Safety and Efficacy of AR/101 in Accelerating Re-epithelialization of Split Thickness Wounds

Role: collaborator

NCT01890837Phase 1Completed

Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)

Role: collaborator

NCT00765700Phase 3Completed

Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury

Role: collaborator

NCT01348152Phase 2Completed

Effect of TU-100 in Patients With Functional Constipation

Role: collaborator

NCT00926068Phase 2Unknown

Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers

Role: collaborator

NCT00871325Phase 1Completed

Effect of TU-100 on Gastrointestinal and Colonic Transit in Humans

Role: collaborator

NCT01139216Phase 1Completed

Effect of TU-100 on Rectal Compliance, Rectal Sensation and Small Bowel and Colonic Transit in Females With Constipation

Role: collaborator

NCT01483846Phase 1Completed

Safety, Tolerability and Pharmacokinetics of Multiple Doses of AV-101 in Healthy Volunteers

Role: collaborator

NCT00677859Phase 1Completed

Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia

Role: collaborator

All 18 trials loaded